NEW YORK, Oct. 31 - Lexicon Genetics yesterday reported a significant fall in total third-quarter revenue atop a strong jump in R&D spending and a surge in net loss.
Revenues for the period ended Sept. 30 were $8 million, compared with $13.5 million during the same quarter one year ago, Lexicon said .
R&D spending in the quarter increased to $19.8 million from $15 million one year ago.
As a result, net loss ballooned to $16.8 million, or $.32 per share, from $6.2 million, or $.12 per share, in the third quarter 2001, the company said.
Lexicon Genetics said it had roughly $119.6 million in cash and investments as of Sept. 30.
Click here for more information.